Bruker | BRKR - Cash And Equivalent



Bruker reported $92M in Cash and Equivalent for its fiscal quarter ending in June of 2025.


Cash And Equivalent Change Date
ABB USD 3.27B 1.23B Jun/2025
Agilent USD 1.54B 49M Jul/2025
Ametek USD 619.71M 220.71M Jun/2025
Bio Techne USD 162.19M 21.52M Jun/2025
Bio-Rad Laboratories USD 369.3M 152.1M Jun/2025
Bruker USD 92M 92.2M Jun/2025
Charles River Laboratories USD 182.82M 46.53M Jun/2025
Danaher USD 2.96B 964M Jun/2025
Exact Sciences USD 657.1M 650.98M Jun/2025
Fujikura JPY 141.66B 43.33B Jun/2025
Furukawa JPY 15.87B 8.98B Jun/2025
General Electric Aerospace USD 10.86B 1.54B Jun/2025
Hitachi JPY 866.24B 143.04B Mar/2025
Hologic USD 1.74B 305.7M Jun/2025
Illumina USD 934M 179M Jun/2025
IQVIA Holdings USD 2.04B 299M Jun/2025
Mettler Toledo International USD 61.82M 2.47M Jun/2025
Mitsubishi Electric JPY 757.33B 23.36B Mar/2025
Mitsubishi Heavy Industries JPY 671.88B 14.06B Jun/2025
Myriad Genetics USD 91.8M 10.6M Mar/2025
Nikon Corporation JPY 164.74B 1.15B Jun/2025
Olympus JPY 241.22B 11.32B Jun/2025
Repligen USD 708.86M 11.63M Jun/2025
Revvity USD 991.85M 145.77M Jun/2025
Smiths GBP 392M 67M Jan/2025
Thermo Fisher Scientific USD 4.58B 442M Jun/2025
Waters USD 367.22M 15.66M Jun/2025